Jamestown  (CVHD)  A (COVID-19) small-scale weekly drive-up testing was Friday August 7 at the Reiland Fine Arts Center parking lot on the University of Jamestown campus.

Central Valley Health District Unit Administrator Robin Iszler says 190 tests were given of the 200 test kits available.

Testing will be offered again August 14, from 10 a.m. to 12 p.m. at the Reiland Fine Arts Center parking lot on the University of Jamestown campus.  There will be a total of 200 tests available (100 for college students, 100 for the general public); and testing will be first come, first serve.

While this testing is open to the general public; the target populations of the event will include college students, COVID-19 close contacts, and/or those exhibiting symptoms.

Appointments are not required but those who wish to receive a test are strongly encouraged to complete the online screening questionnaire in advance, which can be found here: https://testreg.nd.gov/. Completing the online screening questionnaire does not guarantee you a test.

Additional details:

There is no cost for the test and health insurance is not processed.

Proof of residency will not be required.

The testing process itself takes approximately 15 minutes. Wait time in line may be longer.

Those with a positive result will be notified by phone within 24 – 72 hours.

Those with a negative result will be notified by the state notification system within 5 – 7 days.

Testing will be conducted using oral swabs. Antibody testing will not be conducted at this event.

Drive-up testing only. Stay in your vehicle to be tested.

Location of event is subject to change. Follow Central Valley Health on Facebook for event updates.

Robin says around 250-300 test kits,  will be available on August 21 and 22 for college students as they are welcomed on campus at the University of Jamestown. This testing will be strictly for UJ Students.

She adds, “We will no longer be offering large-scale testing events and will be moving towards smaller weekly events to ensure availability of testing for those who are close contact or symptomatic.”